Medacta Group revenue and financials
CHF 114.60Change from previous close: 0.00%
In the fiscal year ended December 2025, Medacta Group reported revenue of €683.83M (+15.79% year over year). Net income was €95.46M, a net margin of 14.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +15.79%
- 2025 vs 2024
- Net income growth
- +30.97%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 12.3%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | 153 | 107 | 75.1 | 73.5 |
| Depreciation and amortization | 74.4 | 65.2 | 57.7 | 51.0 |
| Capital expenditure | -143 | -105 | -82.2 | -71.3 |
| Investing cash flow | -137 | -98.9 | -80.6 | -65.1 |
| Financing cash flow | -18.8 | 4.3 | -10.1 | 3.4 |
| Dividends paid | -14.7 | -11.2 | -11.1 | -10.4 |
| Share repurchases | -6.2 | -4.8 | -3.9 | -2.9 |
| Debt issued | 85.3 | 71.2 | 30.5 | 59.2 |
| Debt repaid | -70.9 | -40.6 | -16.8 | -35.2 |
| Effect of exchange rates | 4.7 | -1.8 | 4.1 | 0.0 |
| Net change in cash | -3.1 | 12.6 | -15.6 | 11.8 |
| Free cash flow | 9.6 | 2.5 | -7.1 | 2.2 |